Axial3D and Biomodex to Collaborate on Fast Production of 3D Brain Aneurysm Models for Procedural Training

November 24, 2021—Axial3D, a medical imaging technology company headquartered in Belfast, United Kingdom, announced a partnership with Biomodex, a developer of biorealistic haptic simulators for physician training and rehearsals. Biomodex is based in Paris, France, and Quincy, Massachusetts.

The partnership will enable Biomodex to speed the production of three-dimensional (3D) printed brain aneurysm models by reducing the time it takes to transform two-dimensional (2D) medical images to 3D visuals. Over the course of a multiyear partnership Axial3D and Biomodex will deliver 3D segmentation and measurement services for complex aneurysm at a large scale and increasingly for cardiovascular applications.

According to Axial3D, the Biomodex Evias solution allows interventional neuroradiologists to simulate interventions in advance to help the physician choose the optimal device and approach for each individual patient. Biomodex uses standard medical imaging to 3D-print precise models of the patient’s unruptured aneurysm. The models are created using multiple advanced materials that simulate the look and feel of the anatomy. The current segmentation process of converting a CT or MRI scan to an accurate 3D visual is resource intensive and time consuming, stated the company.

Axial3D’s artificial intelligence-enabled Segmentation-as-a-Service platform automatically transforms 2D medical images to 3D visuals in minutes. This allows 3D print models of the brain arteries to be produced and distributed within days to an international customer base, stated the company.

“We are incredibly excited to be announcing this partnership with Biomodex,” commented Axial3D Chief Executive Officer (CEO) Roger Johnston in the company’s press release. “Their market offerings are truly groundbreaking for the physicians and patients who benefit from them, and for Axial3D to be further able to fuel their global scaling and in parallel, transform the speed of delivery, providing a higher standard of care to aneurysm patients globally, is inspiring.”

Ziad Rouag, President and CEO of Biomodex, added, “We believe our biorealistic haptic simulators can better prepare physicians for complex aneurysm embolization procedures and have the potential to improve patient outcomes. Axial3D will help us scale production and bring our training solutions to more physicians around the world faster. We’re pleased to have them join our partner ecosystem.”